Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

51.76
-1.0100-1.91%
Pre-market: 51.34-0.4200-0.81%06:00 EDT
Volume:10.76M
Turnover:554.72M
Market Cap:104.69B
PE:13.85
High:52.27
Open:51.07
Low:51.04
Close:52.77
52wk High:61.70
52wk Low:36.19
Shares:2.02B
Float Shares:1.95B
Volume Ratio:3.58
T/O Rate:0.55%
Dividend:1.80
Dividend Rate:3.48%
EPS(TTM):3.74
EPS(LYR):3.74
ROE:40.91%
ROA:10.02%
PB:4.36
PE(LYR):13.85

Loading ...

GSK Cough Drug Failure Disappoints, but Market was Cautious

Dow Jones
·
4 hours ago

Dow Jones Top Company Headlines at 7 PM ET: Walmart Further Shuffles Top Executives | SpaceX ...

Dow Jones
·
Jul 18

GSK plc Stock (GSK) Moved Down by 3.06% on Jul 17: Drivers Behind the Movement

TradingKey
·
Jul 18

Movement Alert|GSK Falls 3.02% in Regular Trading, Discontinues Camlipixant Development After Phase 3 Failure in Refractory Chronic Cough

Market Focus
·
Jul 18

GSK’s ALANIS Trial: Fresh Momentum in AL Amyloidosis Could Reshape Investor Views

TIPRANKS
·
Jul 18

GSK Explores Heart Health Upside From Its Next-Gen Vaccines

TIPRANKS
·
Jul 18

GSK’s New Asthma Injection Study: Early Signals for Long-Term Investors

TIPRANKS
·
Jul 18

European Pharma Stocks' Underperformance Shouldn't Last

Dow Jones
·
Jul 17

GSK Oncology Portfolio Seems Underrated

Dow Jones
·
Jul 17

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday as Investors Retreat From Chipmaker Stocks

MT Newswires Live
·
Jul 17

Sector Update: Healthcare

MT Newswires Live
·
Jul 17

GlaxoSmithKline (GSK) Gets a Buy from Jefferies

TIPRANKS
·
Jul 17

GSK Shares Slide After Drugmaker Drops Chronic Cough Treatment

Dow Jones
·
Jul 17

GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan

TIPRANKS
·
Jul 17

GSK Will Likely Need to Book Write-down on Cough Drug Failure

Dow Jones
·
Jul 17

GSK Stops Camlipixant Program in Refractory Chronic Cough After Phase 3 Data

MT Newswires Live
·
Jul 17

Movement Alert|GSK Falls 4.42% in Pre-Market Trading, Trading at $50.41

Market Focus
·
Jul 17

GSK Halts Camlipixant Development in Chronic Cough After Mixed Phase III Results

TIPRANKS
·
Jul 17

GSK Advances New Infant Pneumococcal Vaccine Into Early-Stage Testing

TIPRANKS
·
Jul 17

GSK Rises Thursday, Outperforms Market

Dow Jones
·
Jul 17